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Human papillomaviruses (HPV) are small double-stranded DNA viruses that replicate as low copy number nuclear plasmids during the
persistent phase. HPVonly possess nine open reading frames but extend their coding capabilities by alternative RNA splicing. We have identified
in cell lines with replicating HPV31 genomes viral transcripts that connect the novel splice donor (SD) sites at nt 1426 and 1534 within the E1
replication gene to known splice acceptors at nt 3295 or 3332 within the E2/E4 region. These transcripts are polyadenylated and are present at low
amounts in the non-productive and productive phase of the viral life cycle. Mutation of the novel splice sites in the context of HPV31 genomes
revealed that the inactivation of SD1534 had only minor effects in short-term replication assays but displayed a low copy number phenotype in
long-term cultures which might be due to the expression of alternative E1^E4 or yet unknown viral proteins. This suggests a regulatory role for
minor splice sites within E1 for papillomavirus replication.
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Persistent infections with human papillomavirus (HPV) types
16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 or 66 are a necessary
risk factor for the development of cervical cancer (Cogliano
et al., 2005). HPV are small viruses with a covalently closed
double stranded DNA genome of approximately 8 kbp in length
and replicate as multicopy extrachromosomal elements in the
persistent phase in human keratinocytes (Stubenrauch and
Laimins, 1999). DNA replication of HPV is regulated by several
viral early proteins in a complex manner. Initiation of replication
at the viral origin requires the viral early proteins E1 and E2
which represent the full-length translation products of the E1 and
the E2 open reading frames (ORF), respectively. E1 is a
replication initiator protein that has weak DNA-specific binding,⁎ Corresponding author. Experimentelle Virologie, Universitaetsklinikum
Tuebingen, Elfriede-Aulhorn-Str. 6, D72076 Tuebingen, Germany. Fax: +49
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doi:10.1016/j.virol.2007.08.026double-stranded DNA melting and helicase activity (Stenlund,
2003; Wilson et al., 2002). E2 forms homodimers that recognize
DNA sequences surrounding the viral origin and helps to target
E1 to the origin through cooperative DNA binding and to ensure
the orderly conversion of the complex to an active helicase
(Stenlund, 2003). In line with this, HPV18 or 31 genomes with
mutations in E1 or E2 are unable to maintain viral genomes as
extrachromosomal elements (Frattini et al., 1996; Karstensen
et al., 2006; Stubenrauch et al., 1998a). Furthermore, expression
of the viral E6 and E7 proteins is required for long-term maint-
enance of HPV31 genomes in human keratinocytes (Thomas
et al., 1999).
The transcription of carcinogenic HPV types 16 and 31
initiates at the major early promoter upstream of the E6 gene or
at the major late promoter within the E7 gene and proceeds to
the early or late polyadenylation signals resulting in polycis-
tronic messages (Hummel et al., 1992; Smotkin and Wettstein,
1986; Zheng and Baker, 2006). HPV16 and 31 use overlapping
reading frames and make extensive use of alternative splicing to
extend their coding capabilities (Hummel et al., 1992; Ozbun,
Fig. 1. The linearized genome of HPV31 (nt 1–7912) with the various ORFs (E1 to E8, L1 and L2) is shown on top. The positions of identified splice donor (SD) and
splice acceptor (SA) sites are indicated by vertical and dashed lines and the respective nucleotide positions are shown below (Hummel et al., 1992; Ozbun, 2002;
Ozbun and Meyers, 1997, 1998a,b; Stubenrauch et al., 2000). The newly identified splice donor sites at nt 1426 and 1534 are highlighted by a grey box.
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2000; Zheng and Baker, 2006). Splicing within the E6 ORF is
required for the maintenance of extrachromosomal HPV31
genomes in keratinocytes and this is thought to be due to
changes in E1 expression levels (Hubert and Laimins, 2002;
Thomas et al., 1999). Furthermore, the linking of a minor
splice donor site within the E1 gene to the major splice ac-Fig. 2. (a) RT-PCR analysis of HPV31 transcripts. RNA isolated from HPV31-positiv
reverse transcribed and amplified by PCR in the presence of primer combinations 31-12
31-3381 R (lanes 5 and 6), 31-1279 F/31-3381 R (lanes 7 and 8), 31-1301 F/31-3630 R
(lanes 13 and 14), 31-1359 F/31-3381R (lanes 15 and 16), 31-2195 F/31-3630R (lane
21 and 22) or 31-2431 F/31-3381 R(lanes 23 and 24). One fifth of the amplification r
visualized by ethidium bromide staining. (b) Nucleotide sequences of the splice sites
intron sequences in lower case. (c) Comparative RT-PCR analysis of HPV31 transcript
CIN612 9E and analyzed with the primer pair 1257/3630 (lanes 1 and 3) or 1359/3630
were visualized by ethidium bromide staining.ceptor site within the E2/E4 region fuses the small E8 ORF to
the C-terminus of the E2 gene resulting in the E8^E2C protein
which is a potent repressor of viral replication (Stubenrauch
et al., 2000). In many HPV types, the viral E4 gene lacks an
ATG start codon and can only be expressed when an upstream
gene is fused to it by alternative splicing. The major E4 species
is a fusion protein between the first five residues of E1 and E4e cells (odd numbered lanes) or normal keratinocytes (even numbered lanes) was
57 F/31-3630R (lanes 1 and 2), 31-1279 F/31-3630R (lanes 3 and 4), 31-1257 F/
(lanes 9 and 10), 31-1301 F/31-3381 R (lanes 11 and 12), 31-1359 F/31-3630 R
s 17 and 18), 31-2195 F/31-3381R (lanes 19 and 20), 31-2431 F/31-3630R (lanes
eaction was separated in a 1% agarose/TAE gel and amplification products were
at nt 1426, 1534, 3295 and 3332. Exon sequences are shown in upper case and
s in different cell lines. RNAwas isolated fromHPV31-positive cell lines LKP1 or
(lanes 2 and 4) and separated in a 1% agarose/TAE gel and amplification products
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1987). E1^E4 represents the most abundantly expressed viral
protein. Genetic analyses revealed that E4 is important for the
amplification of HPV31 genomes in differentiated cells and for
the replication of HPV16 and 18 genomes in undifferentiated and
differentiated cells (Nakahara et al., 2005; Wilson et al., 2005,
2007). The mutation of the major splice acceptor site within the
E2/E4 region of HPV31 resulted in genomes that were repli-
cation-competent in short-term assays but failed to be stably
maintained as extrachromosomal elements (Klumpp et al., 1997).
Taken together, these results suggest that the stable maintenance
of the HPV31 genome is regulated in a very complex manner and
involves alternative splicing of viral transcripts.
The analysis of HPV11-transfected cells presented evidence
that a splice donor site is used downstream of the donor site used
for the generation of E8^E2C and is linked to three different
acceptor sites giving potentially rise to truncated E1 proteins,
alternative E1^E4 proteins and truncated E2 proteins (Chiang
et al., 1991; Renaud and Cowsert, 1996). In this report, we
describe the identification of novel splice sites in the E1 region of
HPV31 that are fused to the major splice acceptor at nt 3295 or a
downstream acceptor site at nt 3332. Genetic analyses of HPV31
mutants unable to use these splice sites reveal a requirement for a
splice donor site at 1534 for maintaining HPV31 genomes at a
normal copy number in human keratinocytes.
Results
Transcripts analyses have identified several splice donor and
acceptor sites throughout the HPV31 genome (Fig. 1; Hummel
et al., 1992; Ozbun, 2002; Ozbun and Meyers, 1997, 1998a,b;
Stubenrauch et al., 2000). Studies with the non-carcinogenic
HPV11 revealed a splice donor site at nt 1459 which is linked to
a splice acceptor upstream of E2, or to two different splice
acceptors within the E2/E4 region (Chiang et al., 1991; Renaud
and Cowsert, 1996). However, no active splice signals have yet
been described for HPV31 or other carcinogenic types in the
region between the splice donor site at nt 1296 in HPV31 and the
acceptor sites at nt 2513 in HPV31 (Fig. 1).
To test whether splice signals are present within the E1
region of HPV31, total RNA was isolated from normal human
keratinocytes or from the LKP1 cell line which harborsFig. 3. (a) RNAse protection analyses of polyA+-RNA isolated from HPV31-
positive cells grown in monolayer (lanes 2, 4, 6, 8) or in organotypic raft cultures
(lanes 1, 3, 5, 7). In lanes 9–12, riboprobes were hybridized to yeast RNA as a
control for the completeness of the RNAse digestion. In lanes 13–16, the
undigested riboprobes and in lane M a 32P-labeled DNA size marker are shown.
Riboprobes encompassing HPV31 nt 679 to 919 (lanes 1, 2, 9 and 13), HPV31 nt
1301–1426/3295–3414 (lanes 3, 4, 10 and 14), HPV31 nt 1301–1426/3332–
3414 (lanes 5, 6, 11 and 15) or HPV31 nt 1359–1534/3295–3414 (lanes 7, 8, 12
and 16) were analyzed. Products were separated in a 5%-urea-polyacrylamide gel
and visualized by exposure to phosphoimager screens. Arrows on the left of lanes
1 and 2 indicate products corresponding to RNAs initiated at P97 and the line
indicates product initiated at P742. Spliced cDNAs in lanes 3–8 are indicated by
asterisks, fragments corresponding to the E1 or E2/E4 exons are indicated by
arrows. (b) Schematic representation of the antisense RNAse protection probes
and the protected fragments. Intron sequences are indicated by dashed lines.
Sizes of protected fragments are shown to the right.extrachromosomal copies of HPV31 and is able to produce
virus upon differentiation (Frattini et al., 1996). RNA (1.5 μg)
was reverse transcribed and amplified by PCR using forward
primers located at nt 1257, 1279, 1301, 1359, 2159 or 2431 and
Fig. 4. Transient replication of HPV31 genomes. SCC13 were transiently
transfected with religated HPV31 wild type (1), HPV31-SD1426mt (2), HPV31-
SD1534mt (3), HPV31-SA3332mt (4), HPV31-SD1426/SD1534mt (5) or
HPV31-SD1426/SD1534/SA3332mt (6) genomes. Low molecular weight DNA
was isolated 5 days post transfection, digested with DpnI and BanII and ana-
lyzed by Southern blot hybridization using a 32P-labeled HPV31 genome as a
probe. Bands were visualized by exposure to phosphoimager screens. The upper
panel represents DpnI-resistant newly replicated DNA, whereas the lower panel
shows DpnI-sensitive non-replicated input material. Comparable results have
been observed in an independent experiment.
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splice donor site in the E2/E4 region at nt 3295 (Fig. 1). As can
be seen in Fig. 2a, the primer combinations 1257/3630 (lanes 1
and 2), 1279/3630 (lanes 3 and 4), 1257/3381 (lanes 5 and 6)
and 1279/3381 (lane 7 and 8) resulted in a prominent product
that was only present in HPV31-positive cells and represents the
previously described spliced RNA for the E8^E2C protein
(Stubenrauch et al., 2000). The primer combinations 1301/3630
(lanes 9 and 10) gave rise to a prominent band of approximately
500 bp in size and minor bands that were only present in
HPV31-positive cells (Fig. 2a). Smaller amplification products
were obtained when using primer combinations 1301/3381
(lanes 11 and 12), 1359/3630 (lanes 13 and 14) or 1359/3381
(lanes 15 and 16) suggesting that they correspond to the
transcripts detected by primers 1301/3630 (Fig. 2a). In contrast
only amplification products corresponding to either unspliced
RNA or viral DNA could be detected with primer combinations
2195/3630 (lanes 17 and 18), 2195/3381 (lanes 19 and 20),
2431/3630 (lanes 21 and 22) or 2431/3381 (lanes 23 and 24) in
HPV31-positive cells (Fig. 2a). Taken together, these data
suggested that novel splice sites exist in the HPV31 E1 gene. To
further characterize the amplification products, cDNAs were
cloned into the pDrive vector. Sequencing of the inserts
revealed the presence of three novel combinations of splice
signals (Figs. 1 and 2b). First, a novel splice donor site at nt
1426 (SD1426) was linked to the known acceptor site at nt 3295
(SA3295) (Hummel et al., 1992); second, the SD1426 was
linked to an acceptor site at nt 3332 (SA3332), that has been
previously described in a different transcript (Ozbun, 2002).
Third, a novel splice donor site at nt 1534 (SD1534) was linked
to SA3295. We next extended our analyses to the biopsy-
derived CIN612 9E cell line that harbors extrachromosomally
replicating HPV31b genomes. As can be seen in Fig. 2c, the
combination of primers 1257 and 3630 resulted in a RT-PCR
product of ∼374 bp in size corresponding to the spliced
E8^E2C mRNA that is identical in CIN612 9E (Fig. 3c, lane 1)
and LKP1 cells (Fig. 3c, lane 3). Also when using primers 1359
and 3630, two major RT-PCR products are visible in both
CIN612 9E and LKP1 cells whose sizes of 519 and 402 bp
correspond to RNAs spliced at 1426 and 3295 and 1534 and
3295 (Fig. 3c, lanes 2 and 4). These findings suggest that the
splice events at SD1426 and SD1534 also occur in a HPV31-
positive cell line isolated from a cervical biopsy.
RT-PCR is a very sensitive technique and may detect small
amounts of aberrantly spliced RNAs. To validate our findings,
total RNAwas extracted from LKP1 cells, mRNAwas isolated
by polyA selection and then polyA+-RNA was analyzed by an
RNAse protection assay. Furthermore, we were interested to
determine whether differences exist between the non-productive
(i.e. cells grown in submerged monolayer) and the productive
cycle of HPV31. Therefore LKP1 cells were grown in
organotypic raft cultures for 12 days and also polyadenylated
RNAwas isolated. As a control for the RNase protection assays,
a probe was used that allows to detect simultaneously initiation
at the major early promoter P97 and at the differentation-
dependent P742 promoter (Stubenrauch et al., 1998a). To detect
the novel transcripts, antisense probes were generated from thecloned cDNA fragments (Fig. 3b). As can be seen in Fig. 3a
using 0.25 μg of polyA+-RNA and the P97/P742 probe
protected fragments of 239 and 198 nt in size hat correspond
to mRNAs initiated at P97 and are either unspliced or spliced at
SD877 (lanes 1 and 2) and do not change upon differentiation
(Stubenrauch et al., 1998a). Also a cluster of protected fragments
of 120 to 175 nt in size is obvious corresponding to initiation at
P742. The intensities of these bands increased when using RNA
from organotypic cultures (lane 1) compared to monolayer cells
(lane 2) which indicated induction of the productive cycle of
HPV31 (Fig. 3a). When using 1 μg of polyA+-RNA and
riboprobes corresponding to the cDNA fragments of RNA
spliced at SD1426/SA3295 (lanes 3 and 4), SD1426/SA3332
(lanes 5 and 6) or SD1534/SA3295 (lanes 7 and 8), protected
fragments of 244, 207 and 294 nt, respectively, are present which
correspond in size to spliced RNAs (Figs. 3a and b). All three
mRNAs were present in both undifferentiated and differentiated
keratinocytes (Fig. 3a, lanes 3–8). The size difference between
the input riboprobes (lanes 14–16) and the protected fragments
(lanes 3–8) indicated successful RNAse digestion of the non-
complementary vector sequences. The absence of protected
fragments in the control digests of the riboprobes hybridized to
yeast RNA (lanes 9–12) further indicates that the appearance of
protected fragments is due to the presence of specific viral
mRNAs (Fig. 3a). In addition, smaller protected fragments
corresponding to only the E2/E4 (119 and 82 nt., respectively) or
the E1 (125 and 175 nt., respectively) exons were also visible
(Figs. 3a and b, lanes 3–8). When comparing the signal
intensities of the P97-specific signals (lanes 3 and 4) with the
signals corresponding to spliced RNA generated by SD1426/
SA3295, SD1426/SA3332 or SD1534/SA3295, it can be
concluded that all three mRNA species are present at low
amounts (Fig. 3a). Taken together the results suggested that
splicing within the E1 gene region at two novel donor sites gives
rise to polyadenylated mRNAs in cells with replicating HPV31
genomes.
In order to address the functional role of SD1426, SD1534
and SA3332, HPV31 genomes were generated by site directed
mutagenesis in which the splice donor and acceptor sites were
inactivated. The mutations of SD1426 (31-SD1426mt, nt 1428
T to A) and SD1534 (31-SD1534mt, nt 1536 T to A) are silent
Fig. 5. (a) Total DNA (10 μg) from normal keratinocytes transfected with HPV31wild type (1), HPV31-SD1426mt (2), HPV31-SD1534mt (3), HPV31-SA3332mt (4),
HPV31-SD1426/SD1534mt (5) or HPV31-SD1426/SD1534/SA3332mt (6) genomes was isolated and analyzed by Southern blot. DNA was either digested with
BamHI, a non-cutter (upper panel) of HPV31 DNA, or with EcoRV (lower panel) which linearizes HPV31 genomes. Hybridizing species were detected with a 32P-
labeled genomic HPV31 probe. Lane S received 100 pg of linearized HPV31 genome. LaneM represents a 32P-labeled DNA size marker. (b) Total DNA (30 ng) derived
from several independent DNA isolations was analyzed in triplicates by real-time PCR using HPV31-specific primers and for a single copy human gene (DKK1). The
values are presented relative to the HPV31 copy number in wild type HPV31-positive cells and corrected for the DKK1 levels as described by Pfaffl (2001). Error bars
indicate standard deviations derived from several independent experiments. (c) RNAwas isolated from normal keratinocytes stably transfected with HPV31 wild type
(1), HPV31-SD1426mt (2), HPV31-SD1534mt (3), HPV31-SA3332mt (4), HPV31-SD1426/SD1534mt (5) or HPV31-SD1426/SD1534/SA3332mt (6) genomes and
analyzed by RT-PCR with primer combinations 31-1301 F and 31-3630 R. PCR products were separated in a 5% polyacrylamide/TBE gel and stained with ethidium
bromide. In lane M, a DNA size marker is shown.
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SA3332mt, nt 3331 G to A) resulted in an amino acid exchange
in the E4 gene but was silent within the transcription/replication
regulator E2 protein. In addition to the single mutants, a double
mutant combining the SD1426 and SD1534 (31-SD1426/
SD1534 mt) mutations and a triple mutant combining the
SD1426, SD1534 and SA3332 (31-SD1426/SD1534/SA3332
mt) mutations were created. To determine whether the
mutations had an influence on the ability of the viral genome
to transiently replicate, transfection experiments were carried
out. Cloned wt and mutant genomes were released from the
vector backbone, religated and transfected into SCC13
keratinocytes grown on mitomycin C-treated NIH3T3 J2 feeder
layers. Transfected cells were maintained for 5 days in culture
and low molecular weight DNA was isolated. DNA was
digested with DpnI to remove non-replicated DNA and BanII
to linearize replicated DNA and then detected by Southern
blotting. As can be seen in Fig. 4, all viral genomes were able to
replicate transiently. However, a slight decrease was noted with
the 31-SD1534mt, 31-SD1426/SD1534 mt and 31-SD1426/
SD1534/SA3332 mt genomes, compared to the HPV31 wt, 31-
SD1426mt and HPV31-SA3332mt (Fig. 4). Taken together, the
results suggested that disruption of splice signals SD1426,
SD1534 or SA3332 does not prevent transient replication of
HPV31 genomes.
To further evaluate whether the long-term maintenance of
HPV31 genomes in normal human keratinocytes is influenced
by splice signal mutations, wild type and mutant genomes were
excised, religated and transfected into human foreskin kerati-
nocytes derived from two different donors. Mock-transfected
keratinocytes ceased to divide whereas wt and mt HPV31-
transfected cells continued to proliferate indicating that the
mutations did not interfere with the immortalizing capabilities
of the virus. In order to evaluate whether inactivation of
SD1426 or SD1534 influenced long-term maintenance of
HPV31 genomes, total cellular DNA was isolated from stably
transfected cells, digested with restriction enzymes that do not
cut (Fig. 5a, upper panel) or cut once (Fig. 5a, lower panel) in
the viral DNA and then analyzed by Southern blotting. Cell
lines transfected with HPV31 wt, SD1426 mt and SA3332 mt
genomes gave rise to three bands consistent with the
extrachromosomal maintenance of these genomes. The analysis
of linearized viral DNA suggested similar viral copy numbers in
these cell lines. In contrast, in cell lines derived by transfection
of 31-SD1534 mt, 31-SD1426/SD1534 mt or 31-SD1426/
SD1534/SA3332 mt, viral DNAwas barely visible by Southern
blotting (Fig. 5a). To quantitate this more accurately, quantita-
tive real-time PCR was performed with HPV31-specific primers
and primers for a single copy human gene (DKK1) to correct for
cell numbers. As shown in Fig. 5b, real-time PCR revealed that
cells transfected with 31-SD1426 mt or 31-SA3332 mt genomes
had similar copy numbers as wt transfected cells. Consistent
with the Southern blot data, viral copy numbers in 31-SD1534
mt, 31-SD1426/SD1534 mt or 31-SD1426/SD1534/SA3332 mt
cells were reduced 7- to 50-fold compared to wt cells. This
suggested that the reduction in copy number is primarily a
consequence of the SD1534 mutation.To test for the effects of the mutations on the processing of
viral transcripts, RNA was isolated from the different cell lines
and analyzed by RT-PCR with primer combinations 31-1301 F
and 31-3630 R. PCR products were separated in a 5%
polyacrylamide/TBE gel and stained with ethidium bromide
(Fig. 5c). RNA isolated from HPV31 wt transfected cells gave
rise to two major RT-PCR products, whose sizes correspond to
the use of SD1426/SA3295 and SD1534/SA3295. In addition,
two minor bands were visible of which one could correspond to
SD1426/SA3332 whereas the identity of the second one is
unknown but its size would be consistent with a splice from
SD1534 to SA3332 (Fig. 5c). In RNA isolated from 31-SD1426
mt transfected cells, the band corresponding to SD1534/SA3295
was present whereas bands corresponding to SD1426/SA3295
or SD1426/SA3332 were absent (Fig. 5c, lane 4). Vice versa in
RNA isolated from 31-SD1534 mt transfected cells, only bands
corresponding to SD1426/SA3295 and SD1426/SA3332 were
detectable whereas products for SD1534 were missing. No
amplification products were obtained with RNA isolated from
either cell lines transfected with the 31-SD1426/SD1534 double
mutant or with the 31-SD1426/SD1534/SA3332 triple mutant
providing further evidence for the knock down of SD1426 and
SD1534 processed transcripts. In contrast, RNA isolated from
31-SA3332 mt transfected cells displayed a similar pattern as wt
cells suggesting that the mutation of SA3332 only had a minor
effect on RNA processing. These data suggest that the splice
donor signal at nt 1534 is required to maintain normal viral copy
numbers in long-term passage cultures.
Discussion
Stable extrachromosomal maintenance of HPV31 genomes
in submerged monolayer cultures requires the presence of the
viral E1, E2, E6, E7 and E8^E2C proteins as well as cis-active
sequences in the regulatory region (Frattini et al., 1996; Hubert
et al., 1999; Longworth et al., 2005; Stubenrauch et al., 1998a,b,
2000; Thomas et al., 1999). Interestingly, also the inactivation
of RNA splicing signals has been shown to modulate HPV31
replication despite the presence of an intact regulatory region
and the E1, E2, E6 and E7 genes (Hubert and Laimins, 2002;
Klumpp et al., 1997; Thomas et al., 1999).
In this study, we have demonstrated that in cell lines
harboring extrachromosomally replicating HPV31 genomes,
two novel splice donor sites within the E1 gene are used that
give rise to polyadenylated mRNAs present at low levels in
undifferentiated and differentiated keratinocytes. A splice donor
site is present at a similar position in the non-carcinogenic
HPV11 (SD1459) suggesting that splice signals within E1
might be conserved among different HPV types (Chiang et al.,
1991; Renaud and Cowsert, 1996). Mutational analyses
revealed that the inactivation of SD1534 slightly impaired
short-term replication and interfered with the long-term
replication of high copy numbers of HPV31 genomes in
keratinocytes despite the presence of intact E1, E2, E6 and E7
genes. The most straightforward interpretation of the SD1534
phenotype is that the fusion of SD1534 with SA3295 gives rise
to a yet unknown viral gene product which is involved in long-
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the E8^E2C protein which is generated upon linking SD1296 to
SA3295 (Stubenrauch et al., 2000). The conceptual translation of
the recovered spliced cDNAs SD1426/SA3295 and SD1534/
SA3295 results in putative novel E1^E4 fusion proteins, which
would differ in the E1 part from the major E1^E4 form in which
the first five residues from E1 are linked to E4 via SA3295
(Doorbar et al., 1986; Hummel et al., 1992; Nasseri et al., 1987).
However, the genetic disruption of the E4 gene downstream of
SA3295, which should prevent expression of all E1^E4 fusion
proteins, had no influence on the genome replication and copy
number of HPV31 in undifferentiated human keratinocytes
(Wilson et al., 2005). In line with this, HPV11 E4 mt genomes
demonstrated wt replication behavior in monolayer cells (Fang et
al., 2006). This suggests that the SD1534 phenotype ismost likely
not due to a lack of expression of alternative E1^E4 proteins.
Another possibility is that the SD1534 splice site is linked to
an acceptor different from SA3295 and that the resulting gene
product accounts for the phenotype. While we have been unable
to recover cDNAs consisting of SD1534 linked to SA3332, RT-
PCR experiments shown in Figs. 2a and 5c suggest that such
transcripts may exist in infected cells. Conceptual translation of
these putative transcripts results in a C-terminally truncated E1
protein which might play a role in long-term replication of
HPV31. However, a comparable C-terminally truncated form of
E1 is not required for long-term replication of BPV1 in mouse
C127 cells (Hubert and Lambert, 1993).
The inactivation of the splice donor and acceptor sequences
within the E6 gene reduced the replication ability of HPV31
genomes in short- and long-term assays (Thomas et al., 1999).
This is thought to be due to a reduced expression of the E1
replication protein, which appears to be translated from a single-
spliced polycistronic mRNA encoding E6⁎, E7 and E1 as the
third ORF (Hubert and Laimins, 2002; Ozbun and Meyers,
1998a). Interestingly, mutation of the major splice donor site at
the beginning of the E1 gene of HPV11 in the context of
expression plasmids increased E1 protein levels and enhanced
replication of origin-containing reporter plasmids suggesting that
also splicing events within the E1 gene regulate E1 expression
(Deng et al., 2003). Thus, usage of SD1534 may influence E1
expression levels in the context of the genomes and the failure of
the mutant to replicate efficiently could be due to a change in E1
levels. Since transcripts spliced at SD1534 may initiate at P97
and end at the early polyadenylation signal downstream of the E5
gene, it is also possible that the translation efficiencies of other
ORFs such as E2 present on the mRNA are influenced by
splicing events. In line with this, it has been shown that splicing
events regulate the translation efficiency of the HPV16 E2
protein (Alloul and Sherman, 1999). E2 is not only required for
initiation of DNA replication but is also necessary as a post-
replicative partitioning factor to prevent genome loss during cell
division (Ilves et al., 1999; Lehman and Botchan, 1998; Piirsoo
et al., 1996; Skiadopoulos and McBride, 1998). A change in E2
expression levels caused by the mutation of SD1534 could also
explain that in short-term assays replication efficiency was only
moderately reduced whereas a dramatic loss of replicating
HPV31 genomes was observed in long-term cultures.Materials and methods
Recombinant plasmids
Plasmid pBR322.HPV31 has been previously described
(Stubenrauch et al., 1998b). Single and double mutations of
splice signals (pBR322-HPV31-SD1426mt, pBR322-HPV31-
SD1534mt, pBR322-HPV31-SA3332mt, pBR322-HPV31-
SD1426/SD1534mt, pBR322-HPV31-SD1426/SD1534/
SA3332mt) were introduced into the HPV31 wild type genome
in the context of pBR322.HPV31 or the respective mutants by
subcloning restriction fragments obtained by overlap-extension
PCR using the appropriate synthetic primers and restriction
digests. Subcloned fragments were analyzed by DNA sequenc-
ing. Plasmid pRP742 has been previously described (Klumpp
et al., 1997). Plasmids pDrive1426/3295 (HPV31 nt 1301–1426
linked to 3295 -3630), pDrive1426/3332 (HPV31 nt 1301–1426
linked to 3332 -3630) and pDrive1534/3295 (HPV31 nt 1359–
1534 linked to 3295–3630) were obtained by cloning RT-PCR
products into plasmid pDrive using the Qiagen PCR cloning kit
(Qiagen, Hilden, Germany) and then the sequence of the cDNAs
was determined. For riboprobe transcription, ZraI (HPV nt 3414)/
SacI or ZraI/SnaBI fragments were deleted from the pDrive
constructs giving rise to pDrive1426/3295-Z, pDrive1426/3332-
Z and pDrive1534/3295-Z.
Purification and analysis of RNA
Total RNAwas isolated from keratinocytes with the RNeasy kit
(Qiagen, Hilden, Germany) and QiaShredder columns (Qiagen,
Hilden, Germany) according to the manufacturer's instructions.
PolyA+-RNAwas isolated from total RNA using the Oligotex kit
(Qiagen, Hilden, Germany) according to the manufacturer's
instructions. Reverse transcriptase-PCR was performed with
1.5 μg of total RNA and combinations of primers 31-1257 F
(5′-GTATGGCAATACTGAAGTGGAA-3′), 31-1279 F (5′-
TGGAAACGCAGCAGATGGTA-3′), 31-1301 F (5′-AGGAG-
CAACAAACAACATTAAG-3′); 31-1359 F (5′-GAAT-
GAAACTCCAACACGTAAT-3′), 31-2195 F (5′-AAGGA-
GTGCCAAAGAAAAACT-3′), 31-2431 F (5′-CCTGTATCTA-
TAGATGTAAAGCA-3′), 31-3381 R (5′-AAGGCGCAG-
GTTTTGGAAT-3′) and 31-3630 R (5′-GACAGCCTATA-
TCTTAAACATT-3′) using the QIAGEN OneStep RT-PCR kit
(Qiagen, Hilden, Germany). Reverse transcription and PCR were
carried according to the manufacturer's instructions.
32P-labeled antisense probes for RNAse protection analyses
were generated from plasmids pRP742 (Klumpp et al., 1997),
pDrive1426/3295-Z, pDrive1426/3332-Z or pDrive1534/3295-
Z using the Riboprobe combination system SP6/T7 (Promega,
Mannheim, Germany). RNA was hybridized to 105 cpm of
antisense probe, digested with RNAses and purified using the
RPAIII kit (Ambion, Darmstadt, Germany) according to the
manufacturer's instructions. Digestion products were separated
in a denaturing urea-polyacrylamide (5%) gel. The dried gel was
exposed to phosphoimager screens and bands were visualized by
using a FujiBAS1800 and the AIDA software package (Raytest,
Berlin, Germany).
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Normal human foreskin keratinocytes (NHK), HPV31-
positive keratinocytes and the SCC13 cell line were cocultured
with mitomycin C-treated NIH3T3 J2 fibroblasts in E-medium
supplemented with 5% fetal bovine serum as described (Frattini
et al., 1996). The generation of HPV31-positive cell lines was
performed as described but without drug selection and cells were
used from two different donors to ensure reproducibility (Frattini
et al., 1996). The LKP1 and the biopsy-derived CIN612 9E cell
line harbor extrachromosomally replicating HPV31 genomes
and have been described previously (Frattini et al., 1996;
Hummel et al., 1992). Organotypic raft cultures of LKP1 cells
were grown without protein kinase C activators as described
previously (Frattini et al., 1996).
Analysis of viral DNA replication
Plasmids (4 μg) containing the various HPV 31 genomes
were digested with EcoRI to release the viral genome from the
cloning vector and then religated under diluted conditions to
facilitate intramolecular ligation. After ethanol precipitation,
religated products were transfected into 5×105 SCC13 cells
grown in 60mmdishes with the use of 15 μl of Lipofectamin and
OptiMem (Invitrogen, Karlsruhe, Germany). The next day, cells
were split into 100 mm dishes and low molecular weight DNA
was isolated 120 h post transfection. Low-molecular-weight
DNAwas purified from transfected cells by digestion with 50 μg
of proteinase K per ml in 400 mM NaCl-10 mM EDTA-10 mM
Tris–HCl (pH 7.5)-0.2% sodium dodecyl sulfate (SDS) at 55 °C
for 3 h; NaCl was added to 1 M, and DNAs were precipitated at
4 °C overnight followed by centrifugation (60 min, 4 °C,
16,000×g). Supernatants were extracted once with phenol-
chloroform-isoamyl alcohol and once with chloroform before
precipitation with isopropanol. Each sample was digested
overnight with 20 U of DpnI, 15 U of BanII and 50 ng of
RNase A prior to Southern analysis. Total cellular DNA was
isolated as described (Stubenrauch et al., 1998b). Analysis of
viral DNA by Southern blot was essentially performed as
described (Stubenrauch et al., 1998a). Briefly, digested DNAs
were separated in a 0.8% agarose gel at 70 V for 16 h. DNAwas
then transferred to a positively charged nylon membrane
(GeneScreen plus, PerkinElmer, Milano, Italy) by alkaline
transfer. Specific 32P-labeled probes to detect viral fragments
were generated with the Ready-to-go DNA labeling kit (GE
Healthcare, Freiburg, Germany). Hybridization and washing of
the blots were performed as described (Stubenrauch et al.,
1998a). Hybridizing DNA species were visualized by autoradi-
ography and visualized by phosphoimaging using a BAS reader
1800 (Raytest, Berlin, Germany). Relative viral copy number in
HPV31-positive cell lines was determined by quantitative real-
time PCR. Real-time PCR was performed on a SDS5700 system
(Applied Biosystems, Darmstadt, Germany) with qPCR™
MasterMix (Eurogentec, Seraing, Belgium) reagents in tripli-
cates. Total DNA (30 ng) was amplified with a HPV31-specific
primer/probe set (31-7335 F 5′-TGTTCCTGCTCCTCCCAA-
TAGT-3′; 31-7541 R 5′-AACCGCAGAACTACTGCATCAG-3′; 31-7464-P Fam-ATGGCTGCATAAAATCAAAATGG-
Tamra) and a human single copy gene (DKK1) primer/probe
set (hDKK1-F 5′-GAGTTCAAGGTGGCGCTCA-3′; hDKK1-
R 5′-GAAAATGACCGTCACTTTGCAA-3′; hDKK1-P Fam-
CGCCGCTACCATCGCGACAAAG-Tamra) for 40 cycles
(15 s denaturation at 95 °C, 1 min primer annealing and exten-
sion at 60 °C). Relative copy numbers were calculated as
described (Pfaffl, 2001).
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